Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Savara Inc. (SVRA)

  • Business News
  • Oct. 27, 2025, 07:19 UTC
  • 7
  • 0 comments

Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SVRA

Market reaction Comment Full text

Lantheus Holdings Inc. (LNTH)

  • Business News
  • Oct. 27, 2025, 07:15 UTC
  • 7
  • 0 comments

Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

Market reaction Comment Full text

Savara Inc. (SVRA)

  • Business News
  • Oct. 27, 2025, 07:13 UTC
  • 6
  • 0 comments

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

Semler Scientific Inc (SMLR)

  • Business News
  • Oct. 27, 2025, 07:12 UTC
  • 7
  • 0 comments

Semler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SMLR

Market reaction Comment Full text

Semler Scientific Inc (SMLR)

  • Business News
  • Oct. 27, 2025, 07:07 UTC
  • 4
  • 0 comments

SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

LifeMD Inc (LFMD)

  • Business News
  • Oct. 27, 2025, 07:04 UTC
  • 4
  • 0 comments

LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD

Market reaction Comment Full text

Smart for Life, Inc. (SMFL)

  • Business News
  • Oct. 27, 2025, 06:00 UTC
  • 2
  • 0 comments

Gender Earnings Gap in Engineering Occupations

Market reaction Comment Full text

Incyte Corporation (INCY)

  • Business News
  • Oct. 27, 2025, 02:02 UTC
  • 3
  • 0 comments

Incyte kündigt neue Daten aus der Phase-3b-Studie TRuE-AD4 zu Opzelura® (Ruxolitinib-Creme) bei Erwachsenen mit mittelschwerer atopischer Dermatitis an

Market reaction Comment Full text

Genenta Science SpA (GNTA)

  • Business News
  • Oct. 27, 2025, 00:30 UTC
  • 5
  • 0 comments

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

Market reaction Comment Full text

Biogen Inc (BIIB)

  • Business News
  • Oct. 26, 2025, 23:30 UTC
  • 7
  • 0 comments

Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease

Market reaction Comment Full text
  • Previous
  • 141
  • 142
  • 143
  • 144
  • 145
  • Next

Search

News categories

  • Technical Exchange News(10333)
  • Event(1541)
  • SEC News(176744)
  • FDA Approval(9672)
  • Company Report(721)
  • Business News(118375)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin